PharmChem Laboratories Inc (PCHM)

[cheddartart]

Y, I agree. Not too impressive so far, but it's still early. No sales for the single largest customer (10%) in Q3 is pretty worrying. The covid boost seems real and won't repeat.

Valuation doesn't seem cheap and maybe a bit expensive if you expect current conditions to only continue.

But they're trying new things to spur sales so it's a risk they're willing to take. It does sound like if it's not working out they'll be quick to change things up and just run it lean for cash flow. It's also worth noting the new CEO hasn't had time to implement any changes.